Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesAntimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.Bloodstream infections in neutropenic cancer patients: A practical update.Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.The challenge of antibiotic resistance in haematology patients.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.Multidrug-resistant bacteria in hematology patients: emerging threats.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury/disorder over the past 9 years.Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality.Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel).Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.Improving the outcome of bloodstream infection in patients with hematological malignancies: looking beyond antibiotics.Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group.Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.Central venous access in oncology: ESMO Clinical Practice Guidelines.Antimicrobial Resistance Pattern and Spectrum of Multiple-drug-resistant Enterobacteriaceae in Iranian Hospitalized Patients with Cancer.Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance.The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignanciesIn vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMAR
P2860
Q26799580-A85BAB7D-4AA5-4230-88DE-DED2841C7EE0Q33760545-BEE39341-606B-4F11-8066-22A5ED1D77E5Q36913345-F465F779-4E86-479E-9AA0-956ED05999C2Q38543852-B5DAE665-82A1-459C-A496-CC9A16BF2044Q38613929-93334738-A9BE-4BEB-939D-87BD6B531FBAQ38620812-08A7016D-E46E-4A08-ABCC-D00254316635Q38749061-B31F1AD4-FA65-441D-AD96-2B4F8C685E18Q38838498-18365822-1C7F-40A7-B4C9-AC313784F0B9Q38875315-8CE6DE58-4AD8-4C34-875C-BAD8FA3CDD84Q39044923-EDABBFF0-4240-4522-BA48-07CD8694EB63Q40332697-BE57AABC-D855-4E4B-8B28-B8014FC5BC08Q40461715-2076E6A0-CB08-4EB3-84C9-633FAFE15666Q40469049-B6CBE3E7-8115-4B6F-8D5E-F488E1924BA5Q40500618-B6B20C1F-37F7-4A87-A6E8-C3E5EB350FF5Q40595790-946EC0E1-884B-404B-B49A-CB1D9D2C1458Q40812219-037867D6-45E4-469F-92A8-5EF340603D18Q41151969-0A16F881-44FC-424B-A47A-B6B5AE3CA54BQ41987005-13AE095E-A61B-4CBD-93B5-17495F37E372Q47574617-127BA654-E731-4449-9653-8679C218BA32Q49816620-EC04841F-C782-4CFE-AE90-D4B782239E2DQ51792973-E63DFD52-F9A0-49FA-AC0F-AFA5E3A1DD12Q55115674-AF8D7DF1-0AD5-43A2-84FB-C5EBBB5D383EQ55496879-FC10B425-7F0F-4841-9C71-7638E9355239Q58770666-F67F9EBC-713D-46E4-9C99-B038D8A49BB0Q59135433-B055964F-EF59-4E31-A042-F582A2848360
P2860
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Current epidemiology and antim ...... ulticentre prospective survey.
@ast
Current epidemiology and antim ...... ulticentre prospective survey.
@en
type
label
Current epidemiology and antim ...... ulticentre prospective survey.
@ast
Current epidemiology and antim ...... ulticentre prospective survey.
@en
prefLabel
Current epidemiology and antim ...... ulticentre prospective survey.
@ast
Current epidemiology and antim ...... ulticentre prospective survey.
@en
P2093
P921
P1476
Current epidemiology and antim ...... multicentre prospective survey
@en
P2093
C Cattaneo
HeMABIS Registry—SEIFEM Group, Italy
M Tumbarello
N Vianelli
P304
P356
10.1016/J.CMI.2014.11.022
P577
2014-12-03T00:00:00Z